Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway.
about
A novel splice variant of GLI1 that promotes glioblastoma cell migration and invasionAberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and ChemoresistanceNon-Canonical Hh Signaling in Cancer-Current Understanding and Future DirectionsThe Role of Hedgehog Signaling in Tumor Induced Bone DiseaseCooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapyBasal cell carcinoma - molecular biology and potential new therapiesContext-dependent signal integration by the GLI code: the oncogenic load, pathways, modifiers and implications for cancer therapyEpidermal growth factor signaling in transformed cellsComputational prediction and experimental verification of new MAP kinase docking sites and substrates including Gli transcription factorsThe Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistanceCompensatory pathways induced by MEK inhibition are effective drug targets for combination therapy against castration-resistant prostate cancerHedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway.More than markers: biological significance of cancer stem cell-defining molecules.cDNA microarray gene expression profiling of hedgehog signaling pathway inhibition in human colon cancer cells.Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.Activation of the Hedgehog pathway in pilocytic astrocytomas.Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.MicroRNA-203 functions as a tumor suppressor in basal cell carcinomaA new tumour suppression mechanism by p27Kip1: EGFR down-regulation mediated by JNK/c-Jun pathway inhibition.Hepatitis C virus-mediated angiogenesis: molecular mechanisms and therapeutic strategies.Inactivation of Patched1 in mice leads to development of gastrointestinal stromal-like tumors that express Pdgfrα but not kit.Targeting Gli transcription activation by small molecule suppresses tumor growth.Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehog-target genes and stabilized expression of GLI1Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors.GLI2 transcription factor mediates cytokine cross-talk in the tumor microenvironment.Regulation of sonic hedgehog expression by integrin β1 and epidermal growth factor receptor in intestinal epitheliumSynergistic inhibition of colon carcinoma cell growth by Hedgehog-Gli1 inhibitor arsenic trioxide and phosphoinositide 3-kinase inhibitor LY294002.Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancerInhibition of extracellular signal-regulated kinases ameliorates hypertension-induced renal vascular remodeling in rat modelsEndosulfan upregulates AP-1 binding and ARE-mediated transcription via ERK1/2 and p38 activation in HepG2 cells.Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation.In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatmentCooperative Hedgehog-EGFR signalingCrosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis.Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cellsDynamic Bayesian Network Modeling of the Interplay between EGFR and Hedgehog Signaling.Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis.Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis.
P2860
Q24309561-355D6E63-8150-4DD7-8E44-F258EB90D8ECQ26775006-5026CDC1-B129-4BFD-A971-24197AAE206FQ26783611-AE263E18-4E75-4FB7-9AEC-225F9A1F4CF9Q26783615-33E58900-F8AD-4F0B-B1C2-0624DA872F00Q26865136-27980E1F-1BCE-41A4-A2B9-BA182ADC73D2Q27006913-F94D8056-564B-4A1B-BE2A-517AEE924B70Q27027214-943938EB-CCF8-4512-9751-B284D3E35DB6Q28084034-BAE3B505-1FA9-4D55-851D-D4D9A0E4CA6CQ28475319-3C7C2944-DB5D-4E5E-AFA2-8264181DD040Q28732811-8BD203C4-6A01-40D2-A071-6E5238278C73Q28833786-EFFE445C-2C64-4690-BC89-80C7068EDA21Q30425261-BB9C9540-E3E0-480F-B3C6-17350BE5DDCBQ33567426-01473BE8-03C5-4A35-A697-FEFA3EFF1E92Q33661278-DBE92782-E4F9-43B0-BDBA-2EF9482679DDQ33721835-B847F71C-AF2D-4E8F-91EF-2FF1811D52EEQ33925506-E91ABFE7-1D12-492B-8B70-F1E2FC0D05E5Q34133052-33E2739C-18AB-4C08-AEF7-9C33567F150FQ34244929-7B627DF8-15E6-482A-B15B-D6C64F2FC495Q34336812-F5E1C474-1AF2-46E3-A200-70BC52DFA2EFQ34406424-67293835-E3F4-4AB6-8BE5-2A50200778BCQ34499002-2F1047A3-43DF-4989-BE08-9C4E80CF3560Q34510184-1B230298-1CE6-43F0-8FA7-625E858A6692Q34728229-0F75FBC6-1A1E-4C47-B022-928BE0F18C33Q34769889-4878F8B8-A89D-4042-BC84-84B9854B817EQ34981146-795CC127-9895-4F83-9593-E612472C5368Q35065222-5DBC4E1F-8D67-4820-996B-95D5B281585BQ35150813-1F57EEFA-D8AB-4163-85C0-2591369DAC2DQ35531884-2CDB03BD-3FD5-4346-B18A-E79F4F158E73Q35602348-9E89AEB9-CD96-445D-AF6A-46011D14F195Q35640296-DE6CB701-0CBF-494F-A24A-A21EFFE82E85Q35669406-1779532A-F305-41EF-8E68-8C926C3FBFC4Q35673434-5050811A-C1F4-4C97-BBFD-0CB7C0B0ED91Q35707004-5F0DE464-2A2F-40CC-B086-E195DC8BE5ABQ35722741-A68B304A-1AC7-49E2-B710-69D180810A90Q35772768-A828D253-2D34-439F-B7D4-5AF72C75D5F2Q35832178-A931AF3E-A8EB-4329-81B0-4237D22C168EQ35835273-1D42F315-001A-4ABF-B017-8CD159B1755CQ35842230-E006427C-36F6-49A6-B593-0A22BA7CC385Q36040432-B510E075-E40A-4555-9FBA-ECA9A971756BQ36065268-B9B4317E-4BBA-47AE-8A8B-802A34094B3D
P2860
Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Epidermal growth factor recept ...... on of the MEK/ERK/JUN pathway.
@ast
Epidermal growth factor recept ...... on of the MEK/ERK/JUN pathway.
@en
Epidermal growth factor recept ...... on of the MEK/ERK/JUN pathway.
@nl
type
label
Epidermal growth factor recept ...... on of the MEK/ERK/JUN pathway.
@ast
Epidermal growth factor recept ...... on of the MEK/ERK/JUN pathway.
@en
Epidermal growth factor recept ...... on of the MEK/ERK/JUN pathway.
@nl
prefLabel
Epidermal growth factor recept ...... on of the MEK/ERK/JUN pathway.
@ast
Epidermal growth factor recept ...... on of the MEK/ERK/JUN pathway.
@en
Epidermal growth factor recept ...... on of the MEK/ERK/JUN pathway.
@nl
P2093
P2860
P50
P1433
P1476
Epidermal growth factor recept ...... on of the MEK/ERK/JUN pathway.
@en
P2093
Cornelia Hauser-Kronberger
Doris Mangelberger
Gerhard Regl
Harald Schnidar
Markus Eberl
Renate Kroismayr
Stefan Klingler
P2860
P304
P356
10.1158/0008-5472.CAN-08-2331
P407
P577
2009-02-03T00:00:00Z